Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

More Than 100 Experimental Treatments Have Been Used in the Fight Against COVID-19

FDA Issues EUA to Baricitinib Plus Remdesivir for COVID-19

0

Emergency use authorization applies to hospitalized patients requiring supplemental oxygen, mechanical ventilation, ECMO

HealthDay Reports: Nearly Half of Coronavirus Infections May Be Asymptomatic

Antibody Treatment Approved for Emergency Use Against Early COVID-19

0

Treatment approved for people newly infected with COVID-19 who are at high risk for progressing to severe disease

Panel Recommends Against Approval of Experimental Drug for Alzheimer Disease

0

FDA panel concluded there is not enough evidence to support the clinical effectiveness of aducanumab

Regulators Discuss Approval of New Alzheimer Disease Drug

0

Aducanumab does not cure or reverse Alzheimer disease; high dose may slow mental decline

The U.S. Food and Drug Administration is requiring labeling changes to nonsteroidal anti-inflammatory drugs that warn of the risks of taking these drugs at 20 weeks of pregnancy or later

FDA Requiring Labeling Changes to NSAIDs Warning of Risks in Pregnancy

0
Labeling must indicate risks to unborn baby with NSAID use at 20 weeks of pregnancy or later
Warning letters have been sent to five companies for illegally selling dietary supplements that contain cesium chloride

FDA Warns Companies About Illegal Sales of Dietary Supplements

0
The supplements contain cesium chloride, but no cesium chloride-containing products are FDA-approved
Regeneron Pharmaceuticals Inc. said Wednesday that it is seeking emergency approval from the U.S. Food and Drug Administration for an experimental antibody cocktail given to President Donald Trump shortly after he was diagnosed with COVID-19.

Maker of Antibody Cocktail Trump Took Seeks Emergency Use Authorization

0
Although effectiveness has not yet been seen in humans, drug has shown promise in treating mild cases of COVID-19
Following weeks of delay

White House Approves Tougher Rules for COVID-19 Vaccine Development

0
Guidelines recommend participants in late-stage trials be followed for a median of at least two months
Eli Lilly and Co. is seeking U.S. approval for emergency use of an experimental antibody therapy for COVID-19.

Company Seeks FDA Emergency Approval for COVID-19 Antibody Therapy

0
Request based on partial clinical trial findings suggesting the drug reduces symptoms in mild or moderate COVID-19
New drug applications for prescription opioids for pain have been based on pivotal trials of short or intermediate duration

New FDA Applications for Opioids Often Based on Short Trials

0
Most products for treating chronic pain approved based on narrowly defined populations of patients